Wednesday, November 18, 2026 | 08:42 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Emcure Pharmaceuticals Ltd Quarterly Results

Q2 FY26-27 Results Summary

Revenue

The revenue stands at ₹2,820.47 crore, reflecting a quarter-on-quarter *(QoQ) increase of 9.30 per cent from ₹2,580.45 crore. This corresponds to a year-on-year *(YoY) growth of 24.26 per cent.

Operating Profit

Operating Profit stands at ₹587.84 crore, reflecting a quarter-on-quarter *(QoQ) increase of 10.39 per cent from ₹532.50 crore. This corresponds to a year-on-year *(YoY) growth of 23.63 per cent.

PBDT

PBDT stands at ₹555.52 crore, reflecting a quarter-on-quarter *(QoQ) increase of 10.43 per cent from ₹503.03 crore. This corresponds to a year-on-year *(YoY) growth of 24.54 per cent.

Profit Before Tax

Profit Before Tax stands at ₹445.86 crore, reflecting a quarter-on-quarter *(QoQ) increase of 13.30 per cent from ₹393.52 crore. This corresponds to a year-on-year *(YoY) growth of 30.59 per cent.

Net Profit

Net Profit stands at ₹325.07 crore, reflecting a quarter-on-quarter *(QoQ) increase of 11.14 per cent from ₹292.49 crore. This represents a 29.32 per cent year-on-year *(YoY) growth for the same year.

  • YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.

Emcure Pharmaceuticals Ltd Earnings

Data not available

Emcure Pharmaceuticals Ltd Earning Charts

Revenue from Operations

in ₹ cr

EBITDA

in ₹ cr

Profit before Tax

in ₹ cr

Net Profit

in ₹ cr

Emcure Pharmaceuticals Ltd Research Reports

ActionTarget Price (₹)BrokerDateReports
Buy 1,695JM Financial25-Nov-2025

Emcure Pharmaceuticals Ltd Financial Reports

Filter By:
Loading...

Emcure Pharmaceuticals Ltd Stock Prices Compare with Peers

Company1 Day1 Week1 month3 month6 month1 Year
Emcure Pharma-0.40%0.45%32.16%23.13%36.23%70.27%
Anthem Bioscienc-0.37%-1.24%14.64%5.12%17.76%44.16%
Ipca Labs.-1.44%-3.62%0.94%-3.79%10.75%26.71%
Glaxosmi. Pharma1.24%0.72%7.42%-11.85%11.95%6.19%
Ajanta Pharma-0.68%0.23%0.88%-10.11%2.59%32.33%
Sai Life-2.50%-7.85%25.61%23.40%55.94%102.97%
Wockhardt0.24%-2.29%5.39%10.08%23.86%51.01%

Company Info

Company Information

Whole Time Director : MUKUND KESHAO GURJAR

CMD & CEO : SATISH RAMANLAL MEHTA

Whole-time Director : NAMITA VIKAS THAPAR

Whole Time Director & COO : SAMIT SATISH MEHTA

Independent Director : Vidya Rajiv Yeravdekar

Independent Director : Vijay Gokhale

Independent Director : Shailesh Ayyangar

Non Executive Director : Samonnoi Banerjee

Company Sec. & Compli. Officer : Amruta Jana Yangalwar

Additional Director : RAMAN PILLAI RAGHU KUMAR

Emcure Pharmaceuticals Ltd News

Data Not Available